Dietary interventions can improve clinical outcomes for some women with breast cancer
the ONA take:
Data from the Women’s Intervention Nutrition Study (WINS) presented at the San Antonio Breast Cancer Symposium demonstrated that reducing dietary intake of fat reduces death rates in some women with early stage breast cancer.
The WINS was a randomized trial, to which 2,437 women ages 48 to 79 years were recruited. The women had early stage hormone-unrelated breast cancer, receiving standard-of-care treatments at 39 centers in the United States. They were randomly assigned to follow a dietary intervention that reduced their fat intake for 5 years following diagnosis (975 patients) or to a control group (1,462 patients).
Centrally trained, registered dietitians implemented the low-fat eating plan via eight biweekly individual counseling sessions and subsequent contacts every 3 weeks, plus unannounced 24-hour telephone recalls performed annually. In addition, the women self-monitored and recorded their fat intake in a book. After more than 15 years of follow-up, death rates from all causes in the intervention group were significantly lower than in the control group.
“The dietary intervention was supported for a median of 5 years,” the researchers reported. Based on their findings, however, the researchers suggest that for lifestyle interventions to have a long-term influence on clinical outcomes, they must be lifelong changes rather than short-term interventions.
Reducing dietary intake of fat reduces death rates in some women with early stage breast cancer.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|